$1.73
-0.10 (-5.46%)
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+2,149.7% upside
Low Target
$24.59
Average Target
$38.92
High Target
$51.00
Current Price
$1.73
Current
$1.73
$1.73
Target
$38.92
$38.92
$24.59
$38.92 avg
$51.00
Scenario Analysis
Bear Case
$24.59
1,321.4%
Low target
Base Case
$38.92
+2,149.7%
Avg target
Bull Case
$51.00
+2,848.0%
High target
Risk/Reward
2.2x
Favorable
Price in Context
52-Week High
$2.68
-35.4% from high
52-Week Low
$0.84
+106.0% from low
Target vs 52W High
$38.92
+1,352.2% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -3.3% |
| AMGN | Hold | 43 | 47% | $190.87 | -54.4% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +138.3% |
| VRTX | Strong Buy | 36 | 81% | $438.34 | -16.9% |
| REGN | Buy | 38 | 68% | $76.80 | -89.8% |
| MRNA | Hold | 30 | 37% | $149.45 | -24.2% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -65.3% |
| RVMD | Strong Buy | 28 | 93% | $114.11 | -43.4% |